These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36311755)

  • 1. Therapeutic effects of Fc gamma RIV inhibition are mediated by selectively blocking immune complex-induced neutrophil activation in epidermolysis bullosa acquisita.
    Haeger SC; Kridin K; Pieper M; Griewahn L; Nimmerjahn F; Zillikens D; König P; Ludwig RJ; Hundt JE
    Front Immunol; 2022; 13():938306. PubMed ID: 36311755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fcγ Receptor IIB Controls Skin Inflammation in an Active Model of Epidermolysis Bullosa Acquisita.
    Kovacs B; Tillmann J; Freund LC; Nimmerjahn F; Sadik CD; Bieber K; Ludwig RJ; Karsten CM; Köhl J
    Front Immunol; 2019; 10():3012. PubMed ID: 31993051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of interferon gamma impairs induction of experimental epidermolysis bullosa acquisita.
    Gross N; Marketon J; Mousavi S; Kalies K; Ludwig RJ; Bieber K
    Front Immunol; 2024; 15():1343299. PubMed ID: 38799441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteolin peracetate and gossypolone inhibit immune complex-mediated neutrophil activation
    Yang K; Yin J; Yue X; Bieber K; Riemekasten G; Ludwig RJ; Petersen F; Yu X
    Front Immunol; 2023; 14():1196116. PubMed ID: 37720234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic identification and functional validation of FcγRIV as key molecule in autoantibody-induced tissue injury.
    Kasperkiewicz M; Nimmerjahn F; Wende S; Hirose M; Iwata H; Jonkman MF; Samavedam U; Gupta Y; Möller S; Rentz E; Hellberg L; Kalies K; Yu X; Schmidt E; Häsler R; Laskay T; Westermann J; Köhl J; Zillikens D; Ludwig RJ
    J Pathol; 2012 Sep; 228(1):8-19. PubMed ID: 22430937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C5aR2 Deficiency Ameliorates Inflammation in Murine Epidermolysis Bullosa Acquisita by Regulating Fcγ Receptor Expression on Neutrophils.
    Seiler DL; Kleingarn M; Kähler KH; Gruner C; Schanzenbacher J; Ehlers-Jeske E; Kenno S; Sadik CD; Schmidt E; Bieber K; Köhl J; Ludwig RJ; Karsten CM
    J Invest Dermatol; 2022 Oct; 142(10):2715-2723.e2. PubMed ID: 35007559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The complement receptor C5aR2 regulates neutrophil activation and function contributing to neutrophil-driven epidermolysis bullosa acquisita.
    Seiler DL; Kähler KH; Kleingarn M; Sadik CD; Bieber K; Köhl J; Ludwig RJ; Karsten CM
    Front Immunol; 2023; 14():1197709. PubMed ID: 37275893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitive Hematopoietic Cells Determine the Extent of Skin Inflammation in Experimental Epidermolysis Bullosa Acquisita.
    Iwata H; Witte M; Samavedam UK; Gupta Y; Shimizu A; Ishiko A; Schröder T; Seeger K; Dahlke M; Rades D; Zillikens D; Ludwig RJ
    J Immunol; 2015 Sep; 195(5):1945-54. PubMed ID: 26202985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The retinoid-related orphan receptor alpha is essential for the end-stage effector phase of experimental epidermolysis bullosa acquisita.
    Sadeghi H; Gupta Y; Möller S; Samavedam UK; Behnen M; Kasprick A; Bieber K; Müller S; Kalies K; de Castro Marques A; Recke A; Schmidt E; Zillikens D; Laskay T; Mariani J; Ibrahim SM; Ludwig RJ
    J Pathol; 2015 Sep; 237(1):111-22. PubMed ID: 25953430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol Off-Target: A New Therapeutic Option in Neutrophil-Dependent Dermatoses?
    Maglie R; Solimani F; Quintarelli L; Hertl M
    J Invest Dermatol; 2020 Dec; 140(12):2326-2329. PubMed ID: 33222759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualization of autoantibodies and neutrophils in vivo identifies novel checkpoints in autoantibody-induced tissue injury.
    Hundt JE; Iwata H; Pieper M; Pfündl R; Bieber K; Zillikens D; König P; Ludwig RJ
    Sci Rep; 2020 Mar; 10(1):4509. PubMed ID: 32161277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model systems duplicating epidermolysis bullosa acquisita: a methodological review.
    Ludwig RJ
    Autoimmunity; 2012 Feb; 45(1):102-10. PubMed ID: 21923614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-type lectin receptor expression is a hallmark of neutrophils infiltrating the skin in epidermolysis bullosa acquisita.
    Guerrero-Juarez CF; Schilf P; Li J; Zappia MP; Bao L; Patel PM; Gieseler-Tillmann J; Murthy S; Cole C; Sverdlov M; Frolov MV; Hashimoto T; Ishii N; Rülicke T; Bieber K; Ludwig RJ; Sadik CD; Amber KT
    Front Immunol; 2023; 14():1266359. PubMed ID: 37799716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDE4 Inhibition as Potential Treatment of Epidermolysis Bullosa Acquisita.
    Koga H; Recke A; Vidarsson G; Pas HH; Jonkman MF; Hashimoto T; Kasprick A; Ghorbanalipoor S; Tenor H; Zillikens D; Ludwig RJ
    J Invest Dermatol; 2016 Nov; 136(11):2211-2220. PubMed ID: 27388992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granzyme B inhibition reduces autoantibody-induced dermal-epidermal separation in an ex vivo model of epidermolysis bullosa acquisita.
    Emtenani S; Lebhar H; Marquis CP; Ludwig RJ; Schmidt E
    Exp Dermatol; 2024 Sep; 33(9):e15172. PubMed ID: 39219105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive but Not Therapeutic Topical Application of Local Anesthetics Can Inhibit Experimental Epidermolysis Bullosa Acquisita in Mice.
    Wen L; Dong X; Li Q; Schramm G; Zhang B; Zillikens D; Ludwig RJ; Petersen F; Yu X
    Front Immunol; 2021; 12():750160. PubMed ID: 34712239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita.
    Bieber K; Witte M; Sun S; Hundt JE; Kalies K; Dräger S; Kasprick A; Twelkmeyer T; Manz RA; König P; Köhl J; Zillikens D; Ludwig RJ
    Sci Rep; 2016 Dec; 6():38357. PubMed ID: 27917914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock protein 90 is required for ex vivo neutrophil-driven autoantibody-induced tissue damage in experimental epidermolysis bullosa acquisita.
    Tukaj S; Hellberg L; Ueck C; Hänsel M; Samavedam U; Zillikens D; Ludwig RJ; Laskay T; Kasperkiewicz M
    Exp Dermatol; 2015 Jun; 24(6):471-3. PubMed ID: 25739426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of epidermolysis bullosa acquisita, an autoimmune subepidermal bullous disease.
    Hashimoto T; Ishii N; Ohata C; Furumura M
    J Pathol; 2012 Sep; 228(1):1-7. PubMed ID: 22692770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GM-CSF modulates autoantibody production and skin blistering in experimental epidermolysis bullosa acquisita.
    Samavedam UK; Iwata H; Müller S; Schulze FS; Recke A; Schmidt E; Zillikens D; Ludwig RJ
    J Immunol; 2014 Jan; 192(2):559-71. PubMed ID: 24337383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.